Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome

@inproceedings{Ma2017SerumCA,
  title={Serum components and clinical efficacies of autologous serum eye drops in dry eye patients with active and inactive Sjogren syndrome},
  author={I-Hsin Ma and Lily Wei Chen and Wen-Hui Tu and Chia-Ju Lu and Chien-Jung Huang and Wei-li Chen},
  booktitle={Taiwan journal of ophthalmology},
  year={2017}
}
PURPOSE Autologous serum eye drops are considered safe and efficient for the treatment of various ocular surface disorders, including dry eye diseases (DED) caused by the primary and secondary Sjogren syndrome (SS). However, the serum components in patients of SS may be different from those of normal patients and can thus lead to unpredictable therapeutic effects. This study divided the SS patients into active and inactive types based on the erythrocyte sedimentation rate and the presence or… CONTINUE READING
BETA